Clinical Trial Update: Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial of pembrolizumab in patients with stage IIb/c melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Melanoma (Skin Cancer) | Phase 2 | Status: RECRUITING